Low Dose Continuous Administration of the Progesterone Receptor Modulator VA2914
Status:
Completed
Trial end date:
2004-12-01
Target enrollment:
Participant gender:
Summary
The purpose of the present study is to evaluate continuous administration of low doses of
VA2914 for potential contraceptive activity and effects on the menstrual cycle and steroid
hormone parameters.